S
BSX icon

Surevest’s Boston Scientific BSX Stock Holding History

Surevest’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$1K Hold
37
– – ﹤0.01% 431
2022
Q2 		$1K Hold
37
– – ﹤0.01% 460
2022
Q1 		$2K Hold
37
– – ﹤0.01% 388
2021
Q4 		$2K Buy
+37
New +$1.55K ﹤0.01% 394

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Surevest's BSX Position: Q3 2022 in Review

Surevest held its Boston Scientific (BSX) position steady in Q3 2022 at 37 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #431.

Surevest first reported a position in BSX in Q4 2021 and has held it in 4 quarters since. The position peaked at $2K in Q1 2022. 864 funds tracked by Wall St. Rank hold BSX as of Q3 2022.

  • Surevest held 37 shares of Boston Scientific worth $1K as of Q3 2022.
  • Surevest left its Boston Scientific share count unchanged in Q3 2022.
  • Boston Scientific made up ﹤0.01% of Surevest's portfolio in Q3 2022, its #431 holding.
  • Surevest first reported a position in Boston Scientific in Q4 2021 and has held it in 4 quarters since.
  • Surevest's Boston Scientific position peaked at $2K in Q1 2022.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.

Based on Surevest's 13F filing for Q3 2022, filed 14 Nov 2022.